Lilly’s new GLP-1 pill just helped people with type 2 diabetes lose over 10% of their body weight in a big trial—yep, that’s about 23 pounds on average! Plus, 75% hit their blood sugar goals. It’s a once-daily pill (not an injection), and it’s giving serious competition to Wegovy. Downsides? Some folks felt nauseous or vomited, but no liver issues. If approved, this could totally shake up the weight loss drug scene! #Health #BodyHealth #GLP1